News
01-09-2013, 12:00 AM
A combination of the drugs pazopanib and paclitaxel shows promise in slowing anaplastic thyroid cancer (ATC), according to a Mayo Clinic-led study published in the journal Science Translational Medicine.
More... (http://www.news-medical.net/news/20130109/Combination-of-pazopanib-and-paclitaxel-shows-promise-in-slowing-anaplastic-thyroid-cancer.aspx)
More... (http://www.news-medical.net/news/20130109/Combination-of-pazopanib-and-paclitaxel-shows-promise-in-slowing-anaplastic-thyroid-cancer.aspx)